NYSE:RMD ResMed Q1 2027 Earnings Report $218.90 -2.25 (-1.02%) Closing price 10/2/2026 03:59 PM EasternExtended Trading$218.94 +0.04 (+0.02%) As of 10/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast ResMed EPS ResultsActual EPSN/AConsensus EPS $2.68Beat/MissN/AOne Year Ago EPSN/AResMed Revenue ResultsActual RevenueN/AExpected Revenue$1.39 billionBeat/MissN/AYoY Revenue GrowthN/AResMed Announcement DetailsQuarterQ1 2027Date10/29/2026TimeAfter Market ClosesConference Call DateThursday, October 29, 2026Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile ResMed Earnings HeadlinesResMed CFO Awarded Performance-Based Equity GrantOctober 1 at 7:10 PM | tipranks.comResMed CEO Farrell Earns Performance-Based Stock GrantOctober 1 at 7:10 PM | tipranks.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.October 3 at 1:00 AM | Banyan Hill Publishing (Ad)ResMed Awards Performance-Based Stock Units to Chief Product OfficerOctober 1 at 7:10 PM | tipranks.comResmed Sets Date for First-Quarter Fiscal 2027 Earnings Release and WebcastOctober 1 at 6:50 PM | tipranks.comResMed Sets 2026 Virtual Annual Meeting and Key Governance VotesOctober 1 at 6:50 PM | tipranks.comSee More ResMed Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ResMed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ResMed and other key companies, straight to your email. Email Address About ResMedResMed (NYSE:RMD) (NYSE: RMD) develops, manufactures and distributes medical equipment and digital health solutions for sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its products include continuous positive airway pressure (CPAP), bilevel and other noninvasive ventilation devices, as well as masks, humidifiers, accessories and diagnostic equipment. The company also provides cloud-connected software and digital health services that support patient monitoring, therapy management and communication among patients, clinicians and care providers. Through its out-of-hospital care offerings, including healthcare software obtained through Brightree, ResMed serves providers involved in home medical equipment, home health and related post-acute care services. ResMed was founded in Australia in 1989 and is headquartered in San Diego, California. The company serves customers and patients in markets around the world through a global network of operations, distributors and healthcare partners. Mick Farrell has served as ResMed’s chief executive officer since 2013.View ResMed ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes Next Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
